The Air Force Medical Service has been compiling rather extensive data on viral hepatitis for some time. These data all reflect our experience with USAF active duty and dependent patients admitted to USAF medical facilities and are based on discharge diagnoses. No reliable outpatient data are available. However, we can reasonably assume that almost all active duty cases have been admitted either to a facility or to quarters, both of which are included in our inpatient data base.
Prior to 1974 the coding system did not distinguish between types: the designation Type B was made only when a case was directly related to postimmunization, to posttransfusion, or to some complicating therapy. All cases not fitting this definition were coded as "infectious hepatitis." General Incidence Table 1 shows the numbers of cases and incidence per 100,000 strength in the Air Force since 1965. These data are from tables which are based on preliminary reports representing 80-90% of the total information on file. Therefore, they should represent accurate trends of the information even if absolute numbers are not complete. It can be seen that both the numbers of cases and the incidence of hepatitis have more than doubled in the decade. These trends are graphically depicted in Figs. 1 and 2. Table 2 summarizes the USAF Medical Facility experience with dependents of USAF active duty in terms of number of cases, average length of hospital stay, and total hospital days by year since 1965. No rates are calculated on this group due to lack of an accurate denominator. We can see, however, that all parameters are decreasing, including the average length of hospitalization. As we will see later, a similar trend in length of illness is evident among active duty cases.
Geographic Distribution
The geographic distribution of hepatitis is shown in Where data were adequate, increases in incidence rates from 1969 to 1974 were 1.5-fold in the continental United States (CONUS), 1.6 in the Far East, and 1.26 in Thailand. The Far East has certainly been our main high risk area in terms of significant numbers of personnel assigned, with only Japan exhibiting rates comparable or lower than those of the CONUS. This is not surprising in view of the level of sanitation in many of the Far Eastern areas.
Incidence by Type
In January 1974, the three Armed Services changed the system for coding viral hepatitis so that data could be collected by type, if known. At the same time, new codes were introduced to determine whether cases of hepatitis might be associated with a history of drug abuse. Table 4 shows USAF experience from January 1974 through June 1975. These are cases in USAF active duty personnel and are again based on discharge diagnoses. These data are more complete than those in Table 1 , so that the total number of cases for 1974 here (1370) is greater than in Table 1 (1125). The relative frequency of each diagnostic category has remained roughly constant on a percentage basis for each time period. Table 5 summarizes Table 4 and indicates that each of the three basic diagnostic categories, i.e., A, B, and "not otherwise specified" (NOS) represents approximately one-third of the total. The actual figures for the 18-month period are 35.6% for Type A, 27.6% for Type B, and 36.8% for the NOS category. This is in contrast to the percent distribution reported for the civilian United States by the Center for Disease Control for 1974 (1) which reported 68 % for Type A, 18 % for Type B, and 14% in the unspecified category.
Relation to Drug Abuse
The relation of hepatitis to drug abuse is shown in Table 6 . Less than 10% of our military cases of viral hepatitis from January 1974 through June 1975 had had a history of documented drug abuse. Additionally, there has been a small decline in the percentage of cases with such a history over the 18-month period. This decline is seen in both the opiate and nonopiate categories. Costs ofHepatitis to the Air Force
Estimates of the cost of viral hepatitis to the Air Force are depicted in Table 7 
